AsOf

Recorded or changed on this day 2026-11-08

901–950 of 46,526 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,765,473,923 shares
AbbVie shares outstanding: 1,765,473,923 shares, claim clm_D979467F30C4 · ended · superseded by clm_2867617AC03A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,587,972,655 shares
AbbVie shares outstanding: 1,587,972,655 shares, claim clm_DA1BB2B2421A · ended · superseded by clm_63D489D3F6EF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 12,094,000,000 United States dollar
AbbVie total equity: 12,094,000,000 United States dollar, claim clm_DA2BBA888E3B · ended · superseded by clm_897825A51216 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 4,926,000,000 United States dollar
AbbVie quarterly revenue: 4,926,000,000 United States dollar, claim clm_DA4F15CF335B · ended · superseded by clm_A7029DF5DA96 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · quarterly revenue · 17,404,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,593,920,285 shares
AbbVie shares outstanding: 1,593,920,285 shares, claim clm_DA54BBD2450C · ended · superseded by clm_A12CA3DA4AB9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 3,577,000,000 United States dollar
AbbVie total equity: 3,577,000,000 United States dollar, claim clm_DC81000AB742 · ended · superseded by clm_0FAC938AA466 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,348,000,000 United States dollar
AbbVie cash and equivalents: 8,348,000,000 United States dollar, claim clm_DCCC204D0954 · ended · superseded by clm_B187D122E493 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 2,278,000,000 United States dollar
AbbVie quarterly operating income: 2,278,000,000 United States dollar, claim clm_DCD9157C9133 · ended · superseded by clm_B8181F382DF3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 53,720,000,000 United States dollar
AbbVie total assets: 53,720,000,000 United States dollar, claim clm_DCE037E09A9F · ended · superseded by clm_10BA5050BC7D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 3,255,000,000 United States dollar
AbbVie quarterly operating income: 3,255,000,000 United States dollar, claim clm_DD94E377758D · ended · superseded by clm_5F0F6A2FD1C5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 752,000,000 United States dollar
AbbVie quarterly operating income: 752,000,000 United States dollar, claim clm_DDFC85B63FE4 · ended · superseded by clm_DD94E377758D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · net income · 11,836,000,000 United States dollar
AbbVie net income: 11,836,000,000 United States dollar, claim clm_DEF5E95E0C29 · ended · superseded by clm_89DC93530D47 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,768,753,829 shares
AbbVie shares outstanding: 1,768,753,829 shares, claim clm_DF17B249782C · ended · superseded by clm_8956DD97BC9C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 68,840,000,000 United States dollar
AbbVie total assets: 68,840,000,000 United States dollar, claim clm_E218878A198F · ended · superseded by clm_212B72E3191E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,769,399,971 shares
AbbVie shares outstanding: 1,769,399,971 shares, claim clm_E2538BAC615B · ended · superseded by clm_10DDA59C62B6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 134,711,000,000 United States dollar
AbbVie total assets: 134,711,000,000 United States dollar, claim clm_E2D8EC5BAEAA · ended · superseded by clm_29497973C1B0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · net income · 5,687,000,000 United States dollar
AbbVie net income: 5,687,000,000 United States dollar, claim clm_E37E3A79E8BD · ended · superseded by clm_FB8073B6F4C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · net income · 5,144,000,000 United States dollar
AbbVie net income: 5,144,000,000 United States dollar, claim clm_E3B87E01B082 · ended · superseded by clm_F05A32E90FA3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 5,218,000,000 United States dollar
AbbVie total equity: 5,218,000,000 United States dollar, claim clm_E3CE62EE8803 · ended · superseded by clm_70ABDD4E760D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 6,452,000,000 United States dollar
AbbVie quarterly revenue: 6,452,000,000 United States dollar, claim clm_E445263E135D · ended · superseded by clm_2A4B013AE0D7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 12,310,000,000 United States dollar
AbbVie quarterly revenue: 12,310,000,000 United States dollar, claim clm_E449A119B758 · ended · superseded by clm_702A9C257ED5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 5,629,000,000 United States dollar
AbbVie cash and equivalents: 5,629,000,000 United States dollar, claim clm_E498EA77B417 · ended · superseded by clm_F526599F9FFE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 16,990,000,000 United States dollar
AbbVie quarterly revenue: 16,990,000,000 United States dollar, claim clm_E6270C8DB4ED · ended · superseded by clm_DA52AAE1BFB4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -2,642,000,000 United States dollar
AbbVie total equity: -2,642,000,000 United States dollar, claim clm_E6BEEAB8A7CC · ended · superseded by clm_6A970AB08DB3 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · headquarters · North Chicago
AbbVie headquarters: North Chicago, claim clm_E74DBC8CCF1E · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 9,391,000,000 United States dollar
AbbVie cash and equivalents: 9,391,000,000 United States dollar, claim clm_E7E1876E4E88 · ended · superseded by clm_2B61F63D78FE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 136,165,000,000 United States dollar
AbbVie total assets: 136,165,000,000 United States dollar, claim clm_E8E57D49C82F · ended · superseded by clm_E991D9CEB134 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 137,182,000,000 United States dollar
AbbVie total assets: 137,182,000,000 United States dollar, claim clm_E991D9CEB134 · ended · superseded by clm_9AD5C074902A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 8,007,000,000 United States dollar
AbbVie total equity: 8,007,000,000 United States dollar, claim clm_E994FFA98EDE · ended · superseded by clm_44F4EB401556 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 27,547,000,000 United States dollar
AbbVie total assets: 27,547,000,000 United States dollar, claim clm_EB461D77BDD4 · ended · superseded by clm_D450CCC758EE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 33,266,000,000 United States dollar
AbbVie revenue: 33,266,000,000 United States dollar, claim clm_EB4D7B27A2A8 · ended · superseded by clm_34A920A5AE6F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,446,000,000 United States dollar
AbbVie cash and equivalents: 8,446,000,000 United States dollar, claim clm_ED592A963798 · ended · superseded by clm_D8002DD7DB3E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 12,569,000,000 United States dollar
AbbVie total equity: 12,569,000,000 United States dollar, claim clm_EEA6EF5889A9 · ended · superseded by clm_B8F0FB3F70F4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 5,040,000,000 United States dollar
AbbVie quarterly revenue: 5,040,000,000 United States dollar, claim clm_EEF0B5482085 · ended · superseded by clm_C287D4F05535 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,766,343,745 shares
AbbVie shares outstanding: 1,766,343,745 shares, claim clm_EF2804D82FE5 · ended · superseded by clm_633C3749CF8B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 8,236,000,000 United States dollar
AbbVie quarterly revenue: 8,236,000,000 United States dollar, claim clm_EF6AEA6051C0 · ended · superseded by clm_7B8BB25C6DC4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 69,342,000,000 United States dollar
AbbVie total assets: 69,342,000,000 United States dollar, claim clm_F03C8BE56D8F · ended · superseded by clm_01E4571FB000 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · net income · 5,953,000,000 United States dollar
AbbVie net income: 5,953,000,000 United States dollar, claim clm_F05A32E90FA3 · ended · superseded by clm_C95C497479DE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 6,088,000,000 United States dollar
AbbVie cash and equivalents: 6,088,000,000 United States dollar, claim clm_F0AF41EB2CBC · ended · superseded by clm_ED592A963798 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -8,172,000,000 United States dollar
AbbVie total equity: -8,172,000,000 United States dollar, claim clm_F246E0A322BD · ended · superseded by clm_4A83CCDD28BD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,768,169,012 shares
AbbVie shares outstanding: 1,768,169,012 shares, claim clm_F33386E6A71F · ended · superseded by clm_7C1384CB0CC0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 1,377,000,000 United States dollar
AbbVie total equity: 1,377,000,000 United States dollar, claim clm_F432E94DBFE8 · ended · superseded by clm_213580F78FFD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,478,332,177 shares
AbbVie shares outstanding: 1,478,332,177 shares, claim clm_F4CDCC85C327 · ended · superseded by clm_0A57708370A6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 5,229,000,000 United States dollar
AbbVie cash and equivalents: 5,229,000,000 United States dollar, claim clm_F526599F9FFE · ended · superseded by clm_E7E1876E4E88 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,759,000,000 United States dollar
AbbVie cash and equivalents: 8,759,000,000 United States dollar, claim clm_F77382A19536 · ended · superseded by clm_8F4CF168CDB2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,593,265,381 shares
AbbVie shares outstanding: 1,593,265,381 shares, claim clm_F79C518E8FAA · ended · superseded by clm_7FD76082DBAA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 1,515,000,000 United States dollar
AbbVie quarterly operating income: 1,515,000,000 United States dollar, claim clm_F8769037DF45 · ended · superseded by clm_9A141AD4FB42 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 2,617,000,000 United States dollar
AbbVie quarterly operating income: 2,617,000,000 United States dollar, claim clm_F92C29C59D1E · ended · superseded by clm_0B42818A10CA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 4,173,000,000 United States dollar
AbbVie quarterly revenue: 4,173,000,000 United States dollar, claim clm_F93636EB7531 · ended · superseded by clm_FEDE06BBE100 · 1 source (1 primary) · conf 0.95

What the statuses mean